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Abstract 
The design of drug delivery systems needs to consider biocompatibility and host body 
recognition for an adequate actuation. In this work, mesoporous silica nanoparticles 
(MSNs) surfaces were successfully modified with two silane molecules to provide 
mixed-charge brushes (-NH3

/-PO3⊝) and well evaluated in terms of surface properties, 
low-fouling capability and cell uptake in comparison to PEGylated MSNs. The 
modification process consists in the simultaneous direct-grafting of hydrolysable short 
chain amino (aminopropyl silanetriol, APST) and phosphonate-based (trihydroxy-silyl-
propyl-methyl-phosphonate, THSPMP) silane molecules able to provide a pseudo-
zwitterionic nature under physiological pH conditions. Results confirmed that both 
mixed-charge pseudo-zwitterionic MSNs (ZMSN) and PEG-MSN display a significant 
reduction of serum protein adhesion and macrophages uptake with respect to pristine 
MSNs. In the case of ZMSNs, his reduction is up to a 70-90% for protein adsorption 
and c.a. 60% for cellular uptake. This pseudo-zwitterionic modification has been 
focused on the aim of local treatment of bacterial infections through the synergistic 
effect between the inherent antimicrobial effect of mixed-charge system and the 
levofloxacin antibiotic release profile. These findings open promising future 
expectations for the effective treatment of bacterial infections through the use mixed-
charge pseudo-zwitterionic MSNs furtive to macrophages and with antimicrobial 
properties. 
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Currently, bone infection represents one of the most common complications in clinical 
practice with serious social and economic implications [1]. It is associated with 
significant morbidity for patients and substantial health care costs. A major issue to be 
considered is the increased multi-drug resistant (MDR) bacteria that is estimated to 
cause more than 10 million deaths via infection for 2050 [2-4]. Therefore, there is a 
great interest to promote new alternative therapies [5-10]. Mesoporous silica 
nanoparticles (MSNs) are highly attractive candidates for targeting drug delivery 
accounting for their special features and were first described for this purpose by Vallet-
Regí in 2001 [11]. Some of these features are their high specific surface area, large and 
tunable pore size, drug loading capacity, simple synthesis, versatility for chemical 
modification and biocompatibility [12]. Consequently, MSNs could be an effective 
solution for infection treatment as it has been recently reported [13]. In this sense, 
MSNs offer the possibility of tackle MDR facilitating cellular accessibility 
(vectorization) and improving drug efficiency due to the ease of surface 
functionalization and high loading ability (therefore, it is possible to tune local drug 
administration avoiding dosage toxic side-effects by reducing the minimum inhibitory 
concentration compared to the free drug) [14]. However, it is known the tendency of 
these nanocarriers to aggregate and undergo nonspecific protein adsorption (formation 
of “protein corona”) when encounter biological fluids. These mechanisms negatively 
affect their efficiency and clearance by the body immune system through macrophage 
fate [15-17]. Therefore, the design of nanoparticles with non-fouling properties against 
proteins is key to reduce their recognition by the immune system and thus optimize their 
applications in nanomedicine [18]. The most commonly used strategy to cloak MSNs 
and increase blood circulation time is grafting with hydrophilic polyethylene glycol 
(PEG) due to its ability to create a steric repulsion barrier against serum proteins 
through a water hydrogen-bound layer [19]. However, PEGylation can increase 
nanoparticle hydrodynamic radius and undergoes oxidation in the presence of oxygen 
and transition metal ions [20].  
Zwitterionic nanoparticles raise a new challenge for the translation of inorganic 
nanoparticles into clinical practice. As described by Laschewsky and Rosenhahn and 




which possess an equal number of both positive and negative charges on the same 
pendant group maintaining overall electrical neutrality [21]. The low-fouling capability 
of zwitterionic surfaces is related to the formation of a hydration layer more strongly 
compared to hydrophilic materials, forming a physical and energetic barrier that hinders 
nonspecific proteins adhesion [22,23]. Initial efforts were focused on the use of 
zwitterionic polymers bearing mixed positively and negatively charged moieties within 
the same chain with an overall charge neutrality [24,25]. In general, the main 
approaches to graft zwitterionic polymers to nanoparticles are: (i) the surface-initiated 
atom transfer radical polymerization (SI-ATRP), which has been applied with 
poly(sulfobetaine) (pSB) [26] and polycarboxybetaine (pCB) derivatives [27] and (ii) 
the surface reversible addition-fragmentation chain transfer (RAFT) applied mainly to 
graft SB copolymers to MSNs [28]. Furthermore, it is possible to confer zwitterionic 
nature by decorating their surface with low-molecular weight moieties bearing the same 
number of negative and positive charges. Although these methods usually require 
several synthetic steps involving different intermediate products, they offer diverse 
advantages compared to zwitterionic polymers since they are relatively more simple and 
lead to more biocompatible surfaces. For example, sulfobetaine derivatives [29] or 
amino acids such as cysteine and lysine can be used [30,31]. In this case, amino acids 
cannot be strictly considered as zwitterions due to the presence of ionizable groups, 
which provides a non-permanent (pH dependent) zwitterion-like behavior at the 
isoelectric point.  
A substantial synthetic advance in the development of zwitterionic-like surfaces of 
biomaterials has been the use of more direct and simple grafting methods based on sol-
gel chemistry with organosilanes
 
[32-34]. In this case, taking advantage of the presence 
of hydroxyl (-OH)-containing biomaterials (i.e. silica) it is feasible to simultaneously 
attach two organosilanes exhibiting functional groups with compensated positive and 
negative charges. Bioceramic surfaces as SBA-15 and hydroxyapatite has been 
modified by this approach to confer surfaces not only of high resistance to nonspecific 
protein adsorption, but also to bacterial adhesion and/or bacterial biofilm [33-35]. This 
strategy allows for tailoring the zwitterionic-like properties of the materials by adjusting 
the molar ratio of the different reactants. 
Herein, MSNs were designed and synthesized via simultaneous direct grafting of short 
chains of amino (aminopropyl silanetriol, APST) and phosphonate-based (trihydroxy-




study is the ease and feasibility of the method, based on the combination of short-chain 
fully hydrolysable silane molecules capable to produce anionic/cationic charge 
separation on the MSNs surface under physiological conditions (pH=7.4), keeping an 
overall electrical neutrality. In this sense, a non-permanent and pH-dependent 
zwitterionic-like behaviour (hereafter named as pseudo-zwitterionic) was obtained. 
Antifouling ability through reduced protein adsorption of serum proteins was evaluated 
by gel electrophoresis (SDS-PAGE) experiments. The low cell uptake against RAW 
264.7 macrophages was proved through laser scanning confocal microscopy and flow 
cytometry assays. For comparative purposes, PEGylated MSNs were fabricated using a 
similarly short chain polymer. This functionalization has been focused on the specific 
infection treatment. Furthermore, the capacity to encapsulate drugs to target bacterial 
infection was assessed through loading with a fluoroquinolone broad-spectrum 
antibiotic as levofloxacin (LEVO).  
 
Materials and Methods 
1. Chemicals 
Fluorescently labelled MCM-41 MSNs were synthesized through a modified Stöber 
reaction [36] by using: tetraethylorthosilicate (TEOS, 98%), sodium hydroxide 2M 
solution (> 97 %, NaOH), cetyltrimethylammonium bromide (> 98%, CTAB), 
aminopropyltriethoxysilane (> 97%, APTES), fluorescein isothiocyanate (> 99%, 
FITC), ammonium nitrate (NH4NO3) and ethanol, all of them purchased from Sigma-
Aldrich and used as-received. Amino-phosphonate functionalization was performed by 
using aminopropyl silanetriol (APST, 96%) and trihydroxy-silyl-propyl-methyl-
phosphonate (THSPMP) obtained from ABCR GmbH & Co. KG. PEGylated 
nanoparticles (PEG) were synthesized by functionalization with 3-
[methoxy(polyethyleneoxy)propyl]trimethoxysilane] of 6-9 units (90%, Gelest) using 
anhydrous toluene (99.8%, Sigma-Aldrich). Solvents of high purity (> 99.5% 2-
propanol, methanol, and toluene) were purchased from Sigma-Aldrich, as well as 
LEVO antibiotic. Deionized water was purified by passage through a Milli-Q 
Advantage A-10 purification system (Millipore Corporation) to a final resistivity of 
18.2 MΩ.cm.  
As-synthesized MSNs were properly characterized through the following methods: 




dynamic light scattering (DLS) and ζ-potential measurements; attenuated total 
reflectance Fourier transform infrared spectroscopy (ATR-FTIR); high resolution magic 
angle spinning (HR-MAS) NMR spectroscopy; solid state MAS NMR and cross 
polarization (CP) MAS NMR spectroscopy; elemental chemical analysis; 
thermogravimetric and differential thermal analysis (TGA); transmission electron 
microscopy (TEM) and scanning electron microscopy (SEM). Description of devices 
and measurement conditions are listed in the Supporting Information. 
2. Synthesis of fluorescently labelled MCM-41 nanoparticles (MSNs) 
Firstly, the silylated labelling solution was prepared by adding 2.2 µL of APTES (0.01 
mmol) to a mixture of 1 mg of FITC (0.0025 mmol) in 0.1 mL of TEOS and stirred at 
room temperature under dark conditions for 2 h. Afterwards 5 mL of TEOS (22.4 
mmol) were added to the mixture and the resulting solution was kept in a syringe 
dispenser. The micelle templating solution was prepared by dissolving 1 g of CTAB 
(2.74 mmol) in 480 mL of water, adding 3.5 mL of NaOH 2 M and heating to 80 ºC 
upon vigorous stirring while keeping a stable vortex for 45 min. Then, the labelling 
solution (APTES-FITC-TEOS) was added at a constant 0.33 mL/min rate and kept 
stirring for 2 h at 80
 
ºC. The resulting colloidal suspension was cooled down in a water 
bath and particles were recovered through washing and centrifuging steps (water, 
ethanol x3). The surfactant template was removed by ion exchange with constant 
overnight stirring and reflux (80 ºC) of nanoparticles suspension in a NH4NO3 
(10g/L):EtOH:H2O (95:5) solution (1 g nanoparticles/350 mL solution). After extraction 
the particles were washed through centrifugation with deionized water and EtOH (x2) 
and dried overnight under vacuum at 30
 
ºC [13].  
3. Synthesis of fluorescent mixed-charge amino-phosphonate pseudo-zwitterionic 
MCM-41 particles (ZMSNs) 
For covalent anchorage of cationic/anionic agents on the external surface of MSNs, the 
initial labelled nanoparticles containing the CTAB template (500 mg) were dried and 
degassed under vacuum overnight and then re-dispersed in 100 mL of absolute EtOH by 
ultrasound cycles (special care was taken to avoid particle agglomeration) for 20 min 
under N2 atmosphere. A mixture of the silane precursors (APST:THSPMP) was 
simultaneously added in varying molar ratios to optimize the pseudo-zwitterionic 




modified from reference [32]. The reaction was kept overnight (inert atmosphere, 
constant stirring and reflux at 80 ºC) before thorough washing and recovery under 
centrifugation with EtOH (x2) and methanol followed by drying overnight under 
vacuum at 30
 
ºC. After outer surface functionalization, ZMSNs were subjected to 
surfactant extraction following the procedure descripted before.  
4. Synthesis of fluorescent PEGylated MCM-41 particles (PEGMSN) 
For PEGylation of the outer surface of MSNs, CTAB-filled labelled colloids were 
degassed overnight and re-suspended in 100 mL of anhydrous toluene under N2 
atmosphere. In this case the alcoxy PEG precursor was added (0.38 mmol/g) to the 
suspension and the reaction underwent overnight at 110
°
C reflux and stirring. The 
product was isolated by centrifugation and subsequent washing with toluene, 2-
propanol, ethanol and methanol. Thorough washing was used in order to minimize the 
possibility of residual toluene existence. For further use the solid nanoparticles were 
dried overnight under vacuum at 30
 
ºC. After outer surface functionalization, PEGylated 
MSNs were subjected to surfactant extraction following the procedure descripted 
before. 
5. Drug loading and ‘‘in vial” release assays 
LEVO was loaded into the inner structure of the MSNs (pores) through impregnation 
method by soaking the dried nanoparticles in a 0.008 M solution of LEVO in absolute 
ethanol (5 mg nanoparticles/mL antibiotic stock solution) [37]. The colloidal suspension 
was stirred at room temperature for 16 h under dark conditions, followed by recovering 
of the product by filtration and drying under vacuum. The amount of LEVO loaded was 
determined by indirect method, calculating the total amount of LEVO released by 
fluorescence and compared with TGA and elemental chemical analyses results. Release 
kinetics of loaded LEVO was determined through fluorescence spectrometry 
(BiotekPowerwave XS spectrofluorimeter, version 1.00.14 of the Gen5 program, with 
λex = 292 nm and λem = 494 nm) under physiological conditions (pH = 7.4, 37 ºC) in 
phosphate buffered solution (PBS) [37]. The system consisted on a double-chamber 
cuvette equipped with sample and analysis compartments separated by a dialysis 
membrane with a 12 kDa molecular weight cut-off membrane allowing selective LEVO 
diffusion. 168 µL of the nanoparticles loaded with LEVO (MSN@LEVO and 




filled with 3.1 mL of PBS. The system was kept at 37 ºC in an orbital shaker (100 rpm) 
refreshing the medium for each time of liquid withdrawing. A calibration curve for the 
LEVO was also acquired 0.02 to 20 µg/mL concentrations. 
 
6. Protein adhesion “in vitro” experiments 
In vitro adhesion of proteins was studied using lysozyme from egg white (90% Lys, 
L6876, Sigma-Aldrich), bovine serum albumin (96% BSA, A2153 Sigma-Aldrich), 
fibrinogen (75% Fib, F8630 Sigma-Aldrich) and protein-rich bovine fetal calf serum 
(FCS). A 50% v/v solution of the proteins (2 mg/mL for Lys, BSA and Fib, 20% v/v in 
the case of FCS in PBS 1x) was gently mixed with MSNs, ZMSNs and PEGylated 
MSNs dispersions (2 mg/mL in PBS 1x) and kept under orbital agitation (200 rpm) for 
24h at 37 ºC. After protein exposure nanoparticles were centrifuged (10000 rpm) and 
washed with PBS in order to remove free or loosely bound proteins and a one-
dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel (SDS-
PAGE) assay was performed. Briefly, the samples were mixed with a buffer (Tris 6 
mM, SDS 2%, glycerol 10%, 2-β-mercaptoethanol 0.5 M, traces of bromophenol blue, 
pH = 6.8) and loaded in 10% SDS-PAGE gels. A calibration curve was estimated by 
loading 0.5, 1.0, 1.5, 2.0 and 2.5 µg/mL protein concentrations. The gels were run with 
a constant 100 V voltage (45-60 min) and stained in R-250 colloidal Coomasie blue 
solution for visualization.  
7. Cell uptake assay 
Macrophage-type murine RAW 264.7 were seeded (5x10
5
 cells/mL) on sterile 24-well 
plates and co-incubated for 90 min with 5 µg/mL suspensions of MSNs, ZMSNs and 
PEG-MSNs samples in complemented Dulbecco´s Modified Eagle´s Medium (DMEM) 
with 10% FBS at 37 °C with 5% CO2. After this period cells were washed twice with 
PBS, and prepared for laser scanning confocal (LSCM) imaging. Therefore, cells were 
fixed with 4% (w/v) paraformaldehyde in PBS with 1% (w/v) sucrose (37 
°
C, 20 min), 
washed with PBS and permeabilized with buffered 0.5% Triton X-100 (10.3 g of 
sucrose, 0.292 g of NaCl, 0.06 g of MgCl2, 0.476 g of 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), and 0.5 mL of Triton X-100 in 100 mL of 
deionized water, pH = 7.4) at 37°C. Non-specific binding sites were blocked with 1% 




565-conjugated phalloidin (dilution 1:40) and 40-6 diamino-20-phenylindole in PBS 
(1M, DAPI), respectively. LSCM images were taken with an Olympus FV1200 using 
488 nm, 563 nm and 405 nm excitation wavelengths for nanoparticles, actin and nuclei, 
respectively. Alternatively, phagocytosis of the fluorescently labelled nanoparticles by 
RAW 264.7 macrophages was evaluated with a FACScalibur Becton Dickinson flow 
cytometer. After 90 min of incubation cells were trypsinized and an aliquot (500 µL) 
was taken and centrifuged (1400 rpm, 5 min) to recover cells. The obtained pellet was 
resuspended in PBS (300 µL) and trypan blue (20 µL) was added to quench 
fluorescence from surface bound nanoparticles, hence distinguish from internalized.  
8. Cell viability assay 
Proliferation of macrophages upon exposure to nanoparticles was determined based on 
the reduction potential of metabolically active cells obtained with AlamarBlue. 
Macrophages were seeded (1x10
6
 cells/mL) on sterile 24-well plates and incubated with 
the MSN, ZMSN and PEGylated nanoparticles for 90 min at 37 °C. Afterwards 10 
µL/well of a 4% AlamarBlue solution (v/v) in DMEM was added and incubated for 3h 
at 37 °C. Fluorescence was measured on a plate reader (Tecan Infinite F200, with λex = 
560 nm and λem = 590 nm). Measurements were taken at least two times in triplicate 
wells per condition in order to obtain proper statistics. 
9. Cytotoxicity of nanoparticles 
Biocompatibility and cytotoxic effects of the studied systems was tested via lactate 
dehydrogenase (LDH) assay in which the cellular membrane damage is related to 
release of cytosolic LDH enzyme (Spinreact S.A., Spain). The concentration of LDH is 
calculated considering its catalytic activity in the reduction of pyruvate by NADH 
which the converts non-fluorescent resazurin to fluorescent resorufin. The supernatant 
of nanoparticles-RAW 264.7 cells incubation experiments is taken and mixed with the 
LDH kit reagents (imidazole 65 mmol/L, pyruvate 0.6 mmol/L and NADH 0.18 
mmol/L). Absorbance at 340 nm wavelength are measured at 0, 1, 2, 3 and 4 min, 
calculating the amount of enzyme that transforms 1 µmol of substrate per minute in 
standard conditions (U/L) as ∆A/min x 4925 (where ∆A is the average difference per 
minute and 4925 corresponds to the correction factor for 25-30 °C). 




Effects against infection of the synthesized nanoparticles was evaluated by incubation 
with anaerobic common pathogens Gram negative Escherichia coli (E. coli) and Gram 
positive Staphylococcus aureus (S. aureus). Dispersions of unloaded (MSN, ZMSN) 
and drug loaded (MSN@LEVO and ZMSN@LEVO) nanoparticles were prepared at 
different concentration (5 and 10 µg/mL) in buffer solution. 500 µL of the suspensions 
were deposited on sterile 24- well plates containing 500 µL of highly concentrated 
bacterial medium (2. 10
8
 bacteria/mL, adjusted by OD600) and cultured for 6 h in an 
orbital shaker (100 rpm) at 37 ºC. After this, aliquots were taken and subsequent 
dilutions (1/100, 1/1000, 1/10000) were performed prior to plate counting agar (PCA) 
evaluation of bacterial survival rate [34]. For this purpose, colony forming units (CFU) 
were calculated after seeding on Luria-Bertani (LB) agar plates and incubating 24 h at 
37 ºC. Results of three independent experiments taken in triplicate were obtained 
through visual inspection and image analysis using adequate thresholding and size cut-
off on FiJi software
 
[38,39].  
11. Statistical Methods 
Experimental data are expressed as mean value ± standard deviation of a representative 
of three independent experiments carried out in triplicate. Statistical analysis of the 
significance of differences was done using one-way ANOVA analysis of variance. A 
value of p <0.05 was considered as statistically significant and denoted with an asterisk 
(*) in the figures.  Statistical differences of p <0.01 were marked with two asterisks 
(**). 
Results and Discussion 
1. Optimization of the synthesis of mixed-charge pseudo-zwitterionic MSNs 
(ZMSNs) 
MCM-41 silica nanoparticles (MSNs) are prepared via modified Stöber method
 
[36,40]. 
FITC is incorporated to the MSNs as a tracer for cell internalization experiments by co-
condensation reaction. Chemical modification of the labelled MSNs is constrained to 
take place on the outer surface of the nanoparticles, thus inner space for antibiotic 
loading is kept filled with the organic template [41] during the bifunctionalization 
processes. Covalent attachment of the amino and phosphonate-based molecules with the 
silanol groups of the silica surface (c.a 9.6 Si-OH/nm
2




condensation reactions in a 1:3 stoichiometry. Fig. 1 displays the synthesis and 
functionalization processes to obtain ZMSNs materials. 
The incorporation of the silanes through organic content of MSNs was quantified from 
TGA and elemental analysis (Table 1 and Fig. S1). Results show a variation of the 
theoretical to experimental APST:THPMSP ratio, evidencing that the amount of 
incorporated APST in the ZMSNs is, in all cases, superior to the theoretical one. This is 
explained by both the lower steric hindrance of the amino-silane molecule and the 
electrostatic repulsion between the negatively charged phosphonate groups and the 
silica matrix. . 
In order to assess the functionalization process, changes in the ζ-potential values of the 
different samples were determined (Table 1). Pure silica MSNs (pka = 6.8) exhibit a 
value of -30 mV due to of presence of deprotonated silanol groups (–Si-O⊝) onto the 
surfaces in physiological conditions. From the ζ-potential it is possible to establish an 
optimal pseudo-zwitterionic activity for a APST:THSMP theoretical molar ratio of 1:1.5 
(standing for ZMSN-1.5). These functionalization composition yields a potential of (5 ± 
3) mV, close to a global zero charge given by the existence of compensated NH3

 and 
PO3⊝ nuclei in an experimental 1:0.71 ratio. Regardless the prevalence of positive 
protonated amino groups provided by an excess of APST, we assume the almost null 
potential is reached due to the co-existence with unreacted surface –Si-O⊝ groups. The 
acid-base equilibrium and corresponding pKa of the different functional groups in 
aqueous medium are represented as follows:  
R-Si-OH  +  H2O  ⇋  R-SiO

  +  H3O
+
  pKa ≈ 6.8   Eq. (1) 
R-PO3-H  +  H2O  ⇋ R-PO3

  +  H3O
+
  pKa ≈ 2.0   Eq. (2) 
R-NH2  +  H2O  ⇋  R-NH3
+
  +  OH

              pKa ≈ 10.                    Eq. (3) 
 
Table 1: Characterization of the samples as a function of APTS:THSMP molar ratio obtained 
by: 
a
elemental chemical analysis (atomic percentages), 
b












 Theoretical Experimental     
MSN __ __ 5.68 0.15 190 ± 4 -30 ± 2 




ZMSN-1.25 1:1.37 1:0.37 10.27 2.43 122 ± 2 25 ± 2 
ZMSN-1.44 1:1.44 1:0.40 12.55 2.53 164 ± 3 25 ± 2 
ZMSN-1.50 1:1.50 1:0.71 12.19 1.80 220 ± 3 5 ± 3 
 
The hydrodynamic diameter (DH) of the synthesized nanoparticles is allocated in the 
range of 122-190 nm, which falls within the tolerance level for nanoparticles [43] and 
reflects no formation of large aggregates in aqueous media. In addition, the small value 
of their standard deviation reflex the homogeneity of the samples (see Fig. S2).  
Fourier transform infrared spectra (FTIR) of pristine and functionalized MSNs (lowest 
(1:1.0) and highest (1:1.5) theoretical APST:THSMP) is shown in Fig. 2A. The 
existence of characteristics bands corresponding to Si-O-Si stretching (1100-900 cm
-1
) 
and Si-O bending (469 cm
-1
) as well as surface unreacted Si-OH (960 cm
-1
) confirm that 
the ordered dense silica network is maintained after functionalization [32]. Besides 
these, it is observed a peak at 560 cm
-1
 which determines defects from the crystalline 
structure [44]. The broad band in the range from 3470 to 3450 cm
-1
 is attributed to the 
O-H stretching vibration of water molecules either adsorbed to the surface Si-OH 
moieties or to themselves through hydrogen bonding [45]. Furthermore, the existence of 
unreacted surface Si-OH groups is revealed from the band located at 960 cm
-1
. The 
grafting reaction of the positively charged molecules (APST) introduces new bands 
corresponding to stretching and deformation modes of protonated NH3

 groups at 3550 
and 1590 cm
-1
, respectively, as well as low intensity primary NH stretching and 
deformation frequency peaks located at 3550 and 1643 cm
-1
, respectively [32]. Bands at 
2952 and 2880 cm
-1
 correspond to symmetric and asymmetric stretching vibrations of 
unreacted propyl residues from the APST. The negatively charged part of the mixed-





shown in the inset of Fig. 2B, the low intensity peak at 1215 cm
-1
 is assigned to the –
P=O linkage of the THSMP [46], whereas the peak located around 975 cm
-1
 
corresponds to the –P-O(H) linkage from the R-PO3⊝ [47]. At lower wavelengths 
stretching bands from P-P and P-OH are found (1007 and 946 cm
-1
, respectively). 
Therefore, the existence of NH3

 and PO3⊝ chains confirm the pseudo-zwitterionic 
modification of MSNs. The optimal aminopropyl:phosphonate molar ratio is established 




henceforth. Pseudo-zwitterionic behavior is furthermore confirmed through zeta-
potential variation as a function of pH. Results show a pH-dependent ζ-potential 
behavior (Fig. S3) given by the contribution of the amino (overall positive charge) or 
the combined phosphonate and silanol moieties (overall negative values) from acidic to 
basic conditions, respectively. A zwitterionic-like charge distribution of overall zero 
potential is observed for the physiological pH range (6.9 to 7.5). 
XRD patterns (Fig. 3A) reveal a 2D hexagonal mesoporous arrangement for both bare 
MSN and functionalized ZMSN-1.5 given by the indexed 10, 11, 20 and 21 reflections 
characteristics of the p6mm crystallographic group [11]. TEM images confirm the 
presence of spherical nanoparticles with a honeycomb-like mesoporous structure 
corresponding to 2D hexagonal arrangement for both bare MSN and functionalized 
ZMSN-1.5 (inset, Fig. 3A). Variations in the textural features of the nanoparticles upon 
pseudo-zwitterionization are calculated from nitrogen adsorption/desorption 
porosimetry and summarized in Table 2. Both isotherms are IV type according to the 
IUPAC, which are present in mesoporous materials with parallel cylindrical pores in a 
2D hexagonal structure [48]. Regarding to SBET and Vp, they display a decrease in 
ZMSNs compared to pristine MSNs, because of the post-grafting of organic moieties 
[49]. This decrease could be attributed to the small size of both functionalizing 
molecules, which may partially block the pore entrances, as previously has been 
reported [13]. These findings are in good agreement with the calculated pore diameter 
(DP) and wall thickness (twall) values, which remain constant in ZMSNs, because the 
functionalization takes place in  the outermost silica surface. Nevertheless, the textural 
parameters of ZMSN-1.5 draw appropriate host characteristics for drug loading and 
targeting delivery on the cylindrical pores (parallel arrangement) of the synthesized 
mesoporous materials.  
 
Table 2. Textural features (SBET: surface area; VP: pore volume; DP: pore diameter; twall: wall 





/g) DP (nm) twall (nm) a0 (nm) 
MSN 1041 1.20 2.40 2.10 4.60 




Solid state NMR spectroscopy is used to assess the covalent bifunctionalization of the 
MSNs (Fig. 4). In the same way, the PEGylated MSNs have been also characterized and 





MAS NMR spectra of the nanoparticles (Fig. 4A) it is observed the presence of residues 
from the templating surfactant and the presence of protonated amino-silane (APST) and 
deprotonated phosphonate-silane (THSPMP) to the surface of the silica framework, 
confirming the polyampholyte nature on the ZMSN surface. Concerning 
29
Si MAS 
NMR studies (Fig. 4B), the appearance of T
n
 bands (R-Si(OSi)n(OH)3-n, n = 2-3) arising 
at -59.6 (T
2
) and -68.1 ppm (T
3
) in the ZMSN-1.5 shows the presence of silane atoms 
bound to an alkyl group and the reaction of Si-OH groups of silane derivatives with 
other Si-OH groups, but it cannot clearly distinguish if the latter ones belong to the 
silica surfaces, to other silane molecules or to a combination of them. In other hand, the 
Q
n




) and -111 ppm (Q
4
) chemical 
shifts correspond to Q
n
 = Si(OSi)n(OH)4-n, n = 2-4, where n values stand for geminal 
silanol (n = 2), one free silanol (n = 3) or fully condensed silica backbone (Q
4
). In this 
sense, the conversion of Si-OH groups of bare MSNs to fully condensed Si-O-Si species 




 peak areas 
and an increase in Q
4






 ratio (Table 3). This 
fact confirms the existence of covalent linkages between silica surfaces and the organic 
groups in the bifunctionalized samples as previously has been reported for other silica 
materials [13]. In addition, the 
31
P MAS NMR profile verifies the existence of 
phosphonate species on the surface of MSN with the sharp and intense peak located at 
24.2 ppm (Fig.4C). Therefore, probably a combination of a silsesquioxane network 
around MSNs together with covalent linkages with the silanol groups from the silica 
surface is occurring in these samples. 
Table 3. Peak area (%) of deconvoluted silicon Qn and Tn  
29
Si MAS NMR bands. 
Sample T2 T3 Q2 Q3 Q4 (Q2+Q3)/Q4 
MSN __ __ 8.7 48.3 42.9 1.33 
ZMSN-1.5 7.0 11.5 5.5 24.0 52.1 0.56 
 
2. Protein adsorption 
Due to the need of relatively long bloodstream circulation times to reach the target and 




adsorption when encounter biological fluids, in vitro adsorption of several proteins 
(lysine, bovine serum albumin, fibrinogen and fetal calf serum) are tested. The low-
adsorbed proteins on the surface of these nanosystems will determine its success in an 
in vivo scenario. Fig. S5 shows results from electrophoresis with buffered Laemmli gel 
(pH = 7.4, 37 °C). ZMSN-1.5 exhibit a significantly lower adsorption against low size 
proteins such as Lys (14.4 kDa), BSA (67 kDa) and Fib (340 kDa) compared to pristine 
MSNs. Furthermore, the reduction in protein corona is comparable to that one yielded 
by the typical PEGylated nanoparticles. The protein adsorption is estimated to be 
reduced in an 80-90% upon functionalization. Considering these results, it is expected 
that our fabricated nanocarriers will not undergo clearance by the immune system as no 




3. In vitro cell internalization 
As it has been previously proposed, cellular uptake of nanoparticles and distribution 
within the cell body is a process governed by several parameters including size, shape, 
charge and chemistry [50,51]. In our study we evaluated internalization into RAW 
264.7 murine macrophague cells of our systems firstly by laser scanning confocal 
microscopy upon incubation with 5 µg/mL nanoparticles dispersions in culture medium 
for 90 min (Fig. 5A). Through labelling cell nuclei, nanoparticles and actin filaments 
with molecules of varying excitation/emission wavelengths (DAPI, λexc = 405 nm, 
FITC, λexc = 488 nm, Atto-565-phall, λexc = 563 nm, respectively), it is possible to run 
co-localization analysis of the nanocarriers. Efficient uptake by macrophagues takes 
place, as expected, when placing in contact with pristine MSNs. Silica nanoparticles are 
localized in the cell cytoplasm not entering the cell nuclei. Cell uptake is drastically 
reduced for functionalized nanoparticles, both ZMSN-1.5 and PEGylated. In both cases, 
fluorescence arising from the green labelled nanoparticles is mainly localized on the 
border of the cell membrane, thus the particles are adsorbed and do not undergo 
engulfment through vesicle formation during the studied 90 min incubation period. The 
ratio of total average fluorescence intensity arising from the nanoparticles (green 
channel) between those within the cells is calculated by image analysis with FiJi 
software (Table S1). Naked MSNs are undergo a 30-40% uptake, while 
bifunctionalization with mixed-charge brushes and PEG reduces engulfment up to 




(Fig. 5C-D), where a reduction of approximately 37% of internalization it is calculated 
for ZMSN-1.5 compared to bare MSN. Therefore, the pseudo-zwitterionic modification 
of the MSNs provides proper stealth properties against immune system since a reduced 
macrophage cell uptake is observed. Furthermore cytotoxic effects on RAW 264.7 cells 
were evaluated through LDH and Alamar Blue tests (Fig. 5B). A slight decrease in cell 
viability was appreciated for all the studied nanoparticles in contact with cells compared 
to control fluorescence, although an overall survival ca. 80% was achieved. In the case 
of LDH experiment, bare MSNs showed a certain cytotoxic effect on macrophages, 
which was noticeably reduced for the PEGylated and mixed-charge pseudo-zwitterionic 
MSNs systems. These findings evidence that since both parameters (low-fouling and 
reduced cell uptake) are comparable in functionalized samples (ZMSN-1.5 and PEG-
MSNs) and significantly lower with respect to bare MSNs, the pseudo-zwitterionic 
surfaces could constitute an alternative to PEGylation. In this sense, such surfaces could 
overcome the oxidative process and formation of undesirable subproducts of PEGylated 
materials [15,22].  
4. “In vial” antibiotic (LEVO) release  
In order to establish the antibiotic releasing efficiency of the low-fouling ZMSN-1.5 
nanoparticles under physiological conditions (pH = 7.4, PBS 1x), we evaluated the time 
evolution of the total amount of antibiotic released normalized with the initial amount of 
loaded molecule (WT = W0) through impregnation method (Fig. 6). This amount of 
loaded LEVO was estimated through elemental analysis at approximately 2% for MSNs 
and 4% for ZMSN-1.5. These results could be explained based on a greater affinity of 
the amine entities present in ZMSNs towards LEVO moieties, which favors the 
incorporation of the antibiotic inside the mesopores, as is it has also been described in 
amine-functionalized MSNs materials
 
[13,52]. Furthermore, N2 adsorption porosimetry 
data of loaded systems verified a much larger reduction in surface area, pore size and 
volume for the ZMSN-1.5 systems, which is in accordance with the larger extent of 
LEVO insertion within the mesopores (see Supporting Information, Table S2). The 
theoretical kinetic model for these systems can be adjusted to a first order kinetic model 
with the Chapman equation (4):  
                                                        WT/W0 = A (1-e
-λt
)
δ                                                   
Eq. (4) 
where WT/W0 represents the percentage of LEVO released at a given time (t), A is the 




parameter, (included as an indicator of the deviation from linearity) and λ the release 
rate constant [13]. ZMSN-1.5 performs a faster drug release (λ = 0.14 h
-1
) than pristine 
MSNs, in a first-order kinetics trend (δ = 1) with and established effective release of 
approximately 40%, and lowering the velocity after 25h. On the other hand, despite the 
kinetics of MSNs is slower at short times, its evolution shows a smoother slow down 
with a possible continuous release even after 60 h in contact with the medium. As stated 
by González et al in the study of dendrimer decorated MSNs, bare silica nanoparticles 
are capable to strongly retain LEVO molecules (up to 50% within 14 days) due to 
hydrogen bonding [13,53]. On the contrary, interactions of the antibiotic molecule with 
protonated amino and phosphonate groups of the ZMSN aid a faster liberation of LEVO 
to the medium, which offers multiple advantages in personalized medicine, when a 
“shock” dose is needed first, followed by a sustained release. Despite a rapid releasing 
time for ZMSN compared to bare MSNs, both samples are capable to deliver 
comparable amounts of antibiotic at the studied times, therefore pseudo-
zwitterionization through bifunctionalization does not affect the amount of delivered 
drug. 
5. Antimicrobial effect  
After evaluating the low-fouling and furtive properties and antibiotic release capability 
of these mixed-charge pseudo-zwitterionic nanosytems in vitro antimicrobial assays 
against pathogenic E. coli and S. aureus were performed to assess the efficacy of these 
nanosystems in an infection scenario. Fig. 7 shows the antimicrobial effect of pristine 
MSN and ZMSN with and without LEVO at lowest concentration (5 g/mL) by 
measurement of the colony forming unit (CFU)/mL. Free-antibiotic pseudo-zwitterionic 
functionalization shows an averaged reduction in bacterial growth allocated circa 47% 
and 74% for E. coli and S. aureus, respectively. On the other hand, upon loading with 
LEVO (5@ and 10@ for the tested nanoparticle suspension concentrations), a notable 
decrease in bacterial survival is shown in both matrices (MSNs and ZMSNs) due to the 
releasing of LEVO to the media. This effect is dosage-dependent, showing high 
antimicrobial effectiveness even to low doses (5 g/mL). However, significant 
differences between both samples containing LEVO are observed, showing higher 
antimicrobial effectively for ZMSN samples compared to MSNs. This could be due to a 
synergistic effect between the inherent antimicrobial properties of free-antibiotic 




antimicrobial efficacy of 99.9 and 100% for ZMSN@LEVO are observed for Gram 
negative and positive bacteria, respectively. Note that for MSN@LEVO, the histogram 
displays bacterial survival above 10
5
 CFU after 6 h of incubation in both pathogens, 
which can be considers as inefficient. It has been reported that a few live bacteria as 10–
100 CFU/mL can cause an infection, increasing the bacterial resistant [54]. However, 
the CFU/mL analysis for ZMSN@LEVO nanosystems displays a remarkable efficiency 
against both Gram-negative and Gram positive bacteria, showing values below of this 
values with significant efficacy.  
Conclusions 
Pseudo-zwitterionic antimicrobial MSNs with low-fouling and reduced macrophage-
uptake behavior has been developed. The pseudo-zwitterionic behavior has been 
acquired by a simple method consisting in simultaneous direct grafting of short chains 
of aminopropyl silanetriol and trihydroxy-silyl-propyl-methyl-phosphonate mixed-
charge brushes onto the external MSN surface. This nanocarrier has been tested for 
local infection treatment through the synergistic effect of antimicrobial effect of mixed-
charges pseudo-zwitterionic surface and the combined levofloxacin release profile 
(burst and sustained release) given by its drug-to-charges electrostatic interactions. An 
excellent antimicrobial activity (>99.9%) against pathogenic E. coli and S. aureus has 
been observed even for low nanoparticles concentration (5 g/mL). The development of 
this simple mixed-charge pseudo-zwitterionic MSN based antimicrobial nanocarriers is 
envisioned to effectively contribute to the field of bacterial infection.  
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Figure and Figure captions 
 







Fig. 2. A) ATR-FTIR spectra of pristine MSN and functionalized ZMSN-1.0 and ZMSN-1.5. B) 
Zoom of the phosphonate bands frequencies 
 
 
Fig. 3. A) Low angle X-ray diffraction patterns and B) N2 adsorption-desorption isotherms of the i) 










C CP-MAS NMR spectra of MSN and ZMSN-1.5 nanoparticles, showing the 
carbon assignment in the upper structure scheme. Peaks corresponding to residual CTAB and 
ethoxy carbons from incomplete hydrolysis and condensation reactions are marked as well with 
# and *, respectively. B) Cross-polarized 
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Si MAS NMR spectra of MSN and ZMSN-1.5. 
Positions and correspondence of the Qn and Tn bands within the silica network are marked. C) 
31







Fig. 5. A) Laser scanning confocal images of the nuclei (DAPI), membrane (Phalloidin) and 
nanoparticles (FITC) emission channels. Merged images and high magnification merged red and 
green channels overlay allow to co-localize the different studied systems (bare MSNs, pseudo-
zwitterion ZMSN-1.5 and control PEGylated MSNs). In the co-localization right row area selection of 
region of interest was done with FiJi, marking in yellow the cell membrane border. Internalized 
nanoparticles are highlighted with yellow arrows, while those located in the outer area are marked 
with white arrows. (Scale bar: 10 µm, 5 µm for co-localization row). B) RAW 264.7 macrophague 
cell survival rate (left axis, blue) and cytotoxic effect of the nanoparticles (right axis, yellow) after 90 
min incubation at 37 °C. Experiments are performed using Alamar Blue
 
and LDH kits, respectively. 
C) Flow cytometry side (SSC-H) versus forward (FSC-H) scatter plots (upper row) and count 
histograms (lower row) showing the internalization of FITC-labelled nanoparticles. D)  Statistical 









Fig. 6. In vitro cumulative LEVO release kinetics of bare MSN and mixed-charge pseudo-





Fig. 7. Antimicrobial activity of bare (MSN) and functionalized (ZMSN-1.5) nanoparticles both 
unloaded (Top set) and LEVO loaded (@,at different concentration ) (Bottom set) against gram-
negative E. coli and gram-positive S. aureus. Results are expressed as colony forming unit (CFU) per 
mL growth of microorganism after 6h incubation. Unloaded samples the lowest concentration is 
shown in order to elucidate the antimicrobial effect. Loaded samples different concentration are 
shown (5, 10) µg/mL in PBS in order to determine the dosage effectiveness. Results and standard 
deviations are calculated from triplicates of three independent experiments, 
*






Herein a novel antimicrobial mixed-charge pseudo-zwitterionic MSNs based system 
with low-fouling and reduced cell uptake behavior has been developed. This chemical 
modification has been performed by the simultaneous grafting of short chain 
organosilanes, containing amino and phosphonate groups, respectively. This nanocarrier 
has been tested for local infection treatment thought the synergistic effect between the 
inherent antimicrobial effect of mixed-charge brushes and the levofloxacin antibiotic 
release profile. 
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